Live Quote · NASDAQBBIOHealthcare· Biotechnology

BridgeBio Pharma, Inc.

$76.03▼ 2.75%($-2.15)
MKT CAP $14.81BNEXT EARNINGS Feb 23, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
30
Valuation
60
Profitability
55
Growth
68
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BBIO research report →

Analyst Price Target
$110.18+44.9% vs. today

Range $87 – $156

Analyst RatingBuy
25 Buy3 Hold0 Sell

Price Chart

+17.66% · this period
$90.17$76.73$63.30Nov 20May 26Nov 20
52-Week Range44% of range
Low
$62.50
Current
$76.03
High
$93.42

AI analysis · Last refreshed November 14, 2026 · Live quote · Not investment advice